Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Montreh Tavakkoli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Case Reports in Oncology|December 7, 2018
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct DiseasesMontreh Tavakkoli, Lisa Mueller
American Journal of Hematology|August 30, 2023
2024 Update: Advances in the risk stratification and management of large B-cell lymphomaMontreh Tavakkoli, Stefan K Barta
Acta Haematologica|September 18, 2014
Survivorship in adolescents and young adultsAshwin Kishtagari, Montreh Tavakkoli, Jae H Park
Development (Cambridge, England)|September 30, 2010
WUSCHEL mediates stem cell homeostasis by regulating stem cell number and patterns of cell division and differentiation of stem cell progenitorsRam Kishor Yadav, Montreh Tavakkoli, G Venugopala Reddy
Expert Opinion on Therapeutic Targets|April 12, 2018
Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?Montreh Tavakkoli, Stephen S Chung, Christopher Y Park
Frontiers in Genetics|December 6, 2014
Pathogenic microRNA's in myeloid malignanciesMona Khalaj, Montreh Tavakkoli, Alec W Stranahan, et al.
Frontiers in Oncology|May 14, 2019
A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung CancerMontreh Tavakkoli, Cy R Wilkins, Jodi V Mones, et al.
Development (Cambridge, England)|June 26, 2014
A high-resolution gene expression map of the Arabidopsis shoot meristem stem cell nicheRam Kishor Yadav, Montreh Tavakkoli, Mingtang Xie, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Cancers|October 16, 2024
Prevalence and Prognostication of CD5+ Mature T-Cell LymphomasOmar Elghawy, Miao Cao, Jason Xu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Case Reports in Oncology|December 7, 2018
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct DiseasesMontreh Tavakkoli, Lisa Mueller
American Journal of Hematology|August 30, 2023
2024 Update: Advances in the risk stratification and management of large B-cell lymphomaMontreh Tavakkoli, Stefan K Barta
Acta Haematologica|September 18, 2014
Survivorship in adolescents and young adultsAshwin Kishtagari, Montreh Tavakkoli, Jae H Park
Development (Cambridge, England)|September 30, 2010
WUSCHEL mediates stem cell homeostasis by regulating stem cell number and patterns of cell division and differentiation of stem cell progenitorsRam Kishor Yadav, Montreh Tavakkoli, G Venugopala Reddy
Expert Opinion on Therapeutic Targets|April 12, 2018
Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?Montreh Tavakkoli, Stephen S Chung, Christopher Y Park
Frontiers in Genetics|December 6, 2014
Pathogenic microRNA's in myeloid malignanciesMona Khalaj, Montreh Tavakkoli, Alec W Stranahan, et al.
Frontiers in Oncology|May 14, 2019
A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung CancerMontreh Tavakkoli, Cy R Wilkins, Jodi V Mones, et al.
Development (Cambridge, England)|June 26, 2014
A high-resolution gene expression map of the Arabidopsis shoot meristem stem cell nicheRam Kishor Yadav, Montreh Tavakkoli, Mingtang Xie, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Cancers|October 16, 2024
Prevalence and Prognostication of CD5+ Mature T-Cell LymphomasOmar Elghawy, Miao Cao, Jason Xu, et al.
Pageof 2